Full Fed. Circ. Won't Review $20M Cialis Marketing Verdict
The full Federal Circuit on Tuesday declined to review whether a panel erred by upholding a $20 million infringement verdict entered in Texas federal court against Eli Lilly & Co. for...To view the full article, register now.
Already a subscriber? Click here to view full article